2,6-Diisopropylphenol - 98%, high purity , GABA-A receptor; anion channel positive allosteric modulator, CAS No.2078-54-8, GABA-A receptor; anion channel positive allosteric modulator

Item Number
D106369
Grouped product items
SKUSizeAvailabilityPrice Qty
D106369-5g
5g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$24.90
D106369-25g
25g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$109.90
D106369-100g
100g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$393.90
D106369-500g
500g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$1,772.90

Basic Description

SynonymsPropofol (USAN:USP:INN:BAN) | PROPOFOL (USP-RS) | PROPOFOL [MART.] | PROPOFOL [EP MONOGRAPH] | 2,6-Bis(1-methylethyl)phenol | 2,6-di(propan-2-yl)phenol | Ivofol | NSC 5105 | Disoprivan | BRN 1866484 | CHEBI:44915 | ICI35,868 | CAS-2078-54-8 | MLS001066348
Specifications & PurityMoligand™, ≥98%
Storage TempProtected from light,Argon charged
Shipped InNormal
GradeMoligand™
Action TypeCHANNEL BLOCKER, INHIBITOR, POSITIVE ALLOSTERIC MODULATOR
Mechanism of actionGABA-A receptor; anion channel positive allosteric modulator
Product Description

Product Introduction

2,6-Diisopropylphenol, a strongly hydrophobic substituted phenol, is a new intravenous anaesthetic. The antioxidant properties of 2,6-diisopropylphenol (Propofol) have been examined. It plays the role of an antioxidant by reacting with free radicals to form a phenoxyl radical, a property associated with all phenol-based free radical scavengers. 2,6-diisopropylphenol is an effective intravenous hypnotic agent, widely used for the induction and maintenance of anesthesia and for sedation in the intensive care unit. It is useful for the induction and maintenance of general anaesthesia.


Application

2,6-Diisopropylphenol is suitable reagent used to study its effect on oxidative phosphorylation of isolated rat liver mitochondria. It is suitable reagent used in the preparation of bis(2,6-diisopropylphenoxy)bis(2-methyl-8-quinolinolato)titanium(IV) complex.

Product Properties

ALogP3.8

Associated Targets(Human)

TRPV4 Tchem Transient receptor potential cation channel subfamily V member 4 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HCN1 Tclin Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HMGCR Tclin HMG-CoA reductase (2475 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
INSR Tclin Insulin receptor (5558 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AR Tclin Androgen Receptor (11781 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACE Tclin Angiotensin-converting enzyme (1423 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA1 Tclin GABA receptor alpha-1 subunit (399 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TSHR Tclin Thyroid stimulating hormone receptor (29986 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD4 Tchem Dopamine D4 receptor (7907 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH2 Tclin Histamine H2 receptor (5428 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1D Tclin Alpha-1d adrenergic receptor (4171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1B Tclin Serotonin 1b (5-HT1b) receptor (2801 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGTR1 Tclin Type-1 angiotensin II receptor (5176 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CALCR Tclin Calcitonin receptor (2215 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1B Tclin Alpha-1b adrenergic receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PPARG Tclin Peroxisome proliferator-activated receptor gamma (15191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR3A Tclin Serotonin 3a (5-HT3a) receptor (3366 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A3 Tclin Dopamine transporter (10535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR4 Tclin Serotonin 4 (5-HT4) receptor (2068 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CACNA1C Tclin Voltage-gated L-type calcium channel alpha-1C subunit (766 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Agtr2 Angiotensin II type 2 (AT-2) receptor (803 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mc4r Melanocortin receptor 4 (1205 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ltc4s Leukotriene C4 synthase (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Sigmar1 Sigma opioid receptor (160 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Npy1r Neuropeptide Y receptor type 1 (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cckar Cholecystokinin A receptor (90 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pde4d Phosphodiesterase 4D (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nos2 Nitric oxide synthase, inducible (3573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapk1 MAP kinase ERK2 (650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Faah Anandamide amidohydrolase (3907 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mmp9 Matrix metalloproteinase 9 (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Glra1 Glycine receptor subunit alpha-1 (65 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HD1 Histone deacetylase (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella pneumoniae (43867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Acinetobacter baumannii (41033 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cryptococcus neoformans (21258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Candida albicans (78123 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Xenopus laevis (337 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Oryctolagus cuniculus (11301 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L929 (3802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FTL Ferritin light chain (43324 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Gabrp GABA-A receptor; anion channel (5731 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Gabrg2 GABA-A receptor; alpha-1/beta-2/gamma-2 (554 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsome (341 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Glra2 Glycine receptor (1745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Gabra1 Gamma-aminobutyric acid receptor subunit alpha-1/beta-2 (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name 2,6-di(propan-2-yl)phenol
INCHI InChI=1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3
InChi Key OLBCVFGFOZPWHH-UHFFFAOYSA-N
Canonical SMILES CC(C)C1=C(C(=CC=C1)C(C)C)O
Isomeric SMILES CC(C)C1=C(C(=CC=C1)C(C)C)O
WGK Germany 3
RTECS SL0810000
PubChem CID 4943
UN Number 2810
Molecular Weight 178.27

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

16 results found

Lot NumberCertificate TypeDateItem
F2413316Certificate of AnalysisJun 01, 2024 D106369
F2413317Certificate of AnalysisJun 01, 2024 D106369
F2413324Certificate of AnalysisJun 01, 2024 D106369
F2109119Certificate of AnalysisMar 11, 2024 D106369
E2410087Certificate of AnalysisMar 11, 2024 D106369
E2410088Certificate of AnalysisMar 11, 2024 D106369
E23061006Certificate of AnalysisApr 06, 2023 D106369
E23061022Certificate of AnalysisApr 06, 2023 D106369
E23061023Certificate of AnalysisApr 06, 2023 D106369
E23061026Certificate of AnalysisApr 06, 2023 D106369
I2209303Certificate of AnalysisJul 24, 2022 D106369
I2209310Certificate of AnalysisJul 24, 2022 D106369
I2209313Certificate of AnalysisJul 24, 2022 D106369
I2209315Certificate of AnalysisJul 24, 2022 D106369
E2225005Certificate of AnalysisMar 27, 2021 D106369
G2220390Certificate of AnalysisMar 27, 2021 D106369

Show more⌵

Chemical and Physical Properties

SolubilityVery slightly soluble in water.
SensitivityAir sensitive;Light sensitive;Heat sensitive
Freezing Point(°C)18 °C
Refractive Index1.514
Flash Point(°F)235.4 °F
Flash Point(°C)113 °C
Boil Point(°C)256°C
Melt Point(°C)18°C

Safety and Hazards(GHS)

Pictogram(s) GHS07
Signal Warning
Hazard Statements

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

H302:Harmful if swallowed

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352:IF ON SKIN: wash with plenty of water.

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P271:Use only outdoors or in a well-ventilated area.

P270:Do not eat, drink or smoke when using this product.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P403+P233:Store in a well-ventilated place. Keep container tightly closed.

P362+P364:Take off contaminated clothing and wash it before reuse.

P330:Rinse mouth.

P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.

P301+P317:IF SWALLOWED: Get medical help.

P337+P317:If eye irritation persists: Get medical help.

P332+P317:If skin irritation occurs: Get medical help.

P319:Get medical help if you feel unwell.

WGK Germany 3
RTECS SL0810000
Merck Index 7834

Related Documents

Citations of This Product

1. Shuai Liu, Keming Zheng, Yilin Jiang, Susu Gai, Bohan Li, Dehai Li, Shuang Yang, Zhihua Lv.  (2023)  Biotransformation of Penindolone, an Influenza A Virus Inhibitor.  MOLECULES,  28  (3): (1479).  [PMID:36771146]
2. Ma Zijian, Ma Yang, Cao Xuefeng, Zhang Yunpeng, Song Tieying.  (2023)  Avenanthramide-C Activates Nrf2/ARE Pathway and Inhibiting Ferroptosis Pathway to Improve Cognitive Dysfunction in Aging Rats.  NEUROCHEMICAL RESEARCH,  48  (2): (393-403).  [PMID:36222956]
3. Jiang Tianze, Xie Laozhi, Zhou Songlei, Liu Yipu, Huang Yukun, Mei Ni, Ma Fenfen, Gong Jingru, Gao Xiaoling, Chen Jun.  (2022)  Metformin and histone deacetylase inhibitor based anti-inflammatory nanoplatform for epithelial-mesenchymal transition suppression and metastatic tumor treatment.  JOURNAL OF NANOBIOTECHNOLOGY,  20  (1): (1-21).  [PMID:36045429]
4. Yujie Tang, Shiyin Zhao, Zemin Peng, Zhen Li, Liang Chen, Pei Gan.  (2021)  Cu2O nanoparticles anchored on carbon for the efficient removal of propofol from operating room wastewater via peroxymonosulfate activation: efficiency, mechanism, and pathway.  RSC Advances,  11  (34): (20983-20991).  [PMID:35479351]
5. Bai Z. M., Li X. F., Yang Y., Yang Y. F., Lv D. R., Tang L. L..  (2021)  Propofol inhibited gastric cancer proliferation via the hsa-miR-328-3p/STAT3 pathway.  Clinical & Translational Oncology,  23  (9): (1866-1873).  [PMID:33772723]
6. Zifei Qin, Peile Wang, Shuyi Duan, Xiaoying Wan, Han Xing, Jing Yang, Xiaojian Zhang, Zhihong Yao, Xinsheng Yao.  (2021)  Potential Determinants for Metabolic Fates and Inhibitory Effects of Isobavachalcone Involving in Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Efflux Transporters.  JOURNAL OF PHARMACEUTICAL SCIENCES,  110  (2285).  [PMID:33610566]
7. Xinqiang Li, Han Xing, Zifei Qin, Jing Yang, Peile Wang, Xiaojian Zhang, Zhihong Yao, Xinsheng Yao.  (2020)  Potential metabolism determinants and drug–drug interactions of a natural flavanone bavachinin.  RSC Advances,  10  (58): (35141-35152).  [PMID:35515695]
8. Xing Han, Yang Jing, Ren Kaidi, Qin Zifei, Wang Peile, Zhang Xiaojian, Yao Zhihong, Gonzalez Frank J, Yao Xinsheng.  (2020)  Investigation on the metabolic characteristics of isobavachin in Psoralea corylifolia L. (Bu-gu-zhi) and its potential inhibition against human cytochrome P450s and UDP-glucuronosyltransferases.  JOURNAL OF PHARMACY AND PHARMACOLOGY,  72  (12): (1865-1878).  [PMID:32750744]
9. Li Yang, Xu Chunxia, Xu Jinjin, Qin Zifei, Li Shishi, Hu Liufang, Yao Zhihong, Gonzalez Frank J, Yao Xinsheng.  (2020)  Characterization of metabolic activity, isozyme contribution and species differences of bavachin, and identification of efflux transporters for bavachin-O-glucuronide in HeLa1A1 cells.  JOURNAL OF PHARMACY AND PHARMACOLOGY,  72  (12): (1771-1786).  [PMID:32648321]
10. Qin Zifei, Jia Mengmeng, Yang Jing, Xing Han, Yin Zhao, Yao Zhihong, Zhang Xiaojian, Yao Xinsheng.  (2020)  Multiple circulating alkaloids and saponins from intravenous Kang-Ai injection inhibit human cytochrome P450 and UDP-glucuronosyltransferase isozymes: potential drug–drug interactions.  Chinese Medicine,  15  (1): (1-18).  [PMID:32655683]
11. Yang Li, Jinjin Xu, Chunxia Xu, Zifei Qin, Shishi Li, Liufang Hu, Zhihong Yao, Frank J. Gonzalez, Xinsheng Yao.  (2020)  Metabolism and disposition of corylifol A from Psoralea corylifolia: metabolite mapping, isozyme contribution, species differences and identification of efflux transporters for corylifol A-O-glucuronide in HeLa1A1 cells.  XENOBIOTICA,  50  (8): (997-1008).  [PMID:32116078]
12. Li Wang, Xiaodan Hong, Zhihong Yao, Yi Dai, Guoping Zhao, Zifei Qin, Baojian Wu, Frank J. Gonzalez, Xinsheng Yao.  (2018)  Glucuronidation of icaritin by human liver microsomes, human intestine microsomes and expressed UDP-glucuronosyltransferase enzymes: identification of UGT1A3, 1A9 and 2B7 as the main contributing enzymes.  XENOBIOTICA,      [PMID:28443723]
13. Zhihong Yao, Shishi Li, Zifei Qin, Xiaodan Hong, Yi Dai, Baojian Wu, Wencai Ye, Frank J. Gonzalez, Xinsheng Yao.  (2017)  Characterization of human UDP-glucuronosyltransferases responsible for glucuronidation and inhibition of norbakuchinic acid, a primary metabolite of hepatotoxicity and nephrotoxicity component bakuchiol in Psoralea corylifolia L..  RSC Advances,  (83): (52661-52671).  [PMID:]
14. Chunli Qi,Jiangnan Fu,Huinan Zhao,Huijie Xing,Dong Dong,Baojian Wu.  (2018-02-14)  Identification of UGTs and BCRP as potential pharmacokinetic determinants of the natural flavonoid alpinetin..  Xenobiotica; the fate of foreign compounds in biological systems,  49  ((3)): (276-283).  [PMID:29436891]

References

1. Yip GM, Chen ZW, Edge CJ, Smith EH, Dickinson R, Hohenester E, Townsend RR, Fuchs K, Sieghart W, Evers AS et al..  (2013)  A propofol binding site on mammalian GABAA receptors identified by photolabeling..  Nat Chem Biol,  (11): (715-20).  [PMID:24056400]
2. C Frenkel,B W Urban.  (1991-09-12)  Human brain sodium channels as one of the molecular target sites for the new intravenous anaesthetic propofol (2,6-diisopropylphenol)..  European journal of pharmacology,  208  ((1)): (75-79).  [PMID:1657621]
3. Paul E Marik.  (2004-12-08)  Propofol: therapeutic indications and side-effects..  Current pharmaceutical design,  10  ((29)): (3639-3649).  [PMID:15579060]
4. Michael A Hall,Jin Xi,Chong Lor,Shuiping Dai,Robert Pearce,William P Dailey,Roderic G Eckenhoff.  (2010-07-06)  m-Azipropofol (AziPm) a photoactive analogue of the intravenous general anesthetic propofol..  Journal of medicinal chemistry,  53  ((15)): (5667-5675).  [PMID:20597506]
5. Zhichao Liu,Qiang Shi,Don Ding,Reagan Kelly,Hong Fang,Weida Tong.  (2011-12-24)  Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps)..  PLoS computational biology,  ((12)): (e1002310-e1002310).  [PMID:22194678]
6. Alexander Meining.  (2012-09-14)  [Colonoscopy: propofol well suited for sedation]..  Deutsche medizinische Wochenschrift (1946),  137  ((38)): (1844-1844).  [PMID:22971967]
7. Borna Ghosh,Kenneth A Satyshur,Cynthia Czajkowski.  (2013-05-04)  Propofol binding to the resting state of the gloeobacter violaceus ligand-gated ion channel (GLIC) induces structural changes in the inter- and intrasubunit transmembrane domain (TMD) cavities..  The Journal of biological chemistry,  288  ((24)): (17420-17431).  [PMID:23640880]
8. UnCheol Lee,SeungWoo Ku,GyuJeong Noh,SeungHye Baek,ByungMoon Choi,George A Mashour.  (2013-05-23)  Disruption of frontal-parietal communication by ketamine, propofol, and sevoflurane..  Anesthesiology,  118  ((6)): (1264-1275).  [PMID:23695090]
9. Albert Dahan,Margot Roozekrans,Rutger van der Schrier,Terry Smith,Leon Aarts.  (2013-05-24)  Primum non nocere or how to resolve drug-induced respiratory depression..  Anesthesiology,  118  ((6)): (1261-1263).  [PMID:23698342]
10. Mami Sasao-Takano,Kan Misumi,Masayuki Suzuki,Yoko Kamiya,Izumi Noguchi,Hiroshi Kawahara.  (2013-06-15)  Propofol drip infusion anesthesia for MRI scanning: two case reports..  Anesthesia progress,  60  ((2)): (60-66).  [PMID:23763561]
11. Zakaria Messieha.  (2013-06-15)  Prevention of sevoflurane delirium and agitation with propofol..  Anesthesia progress,  60  ((2)): (67-71).  [PMID:23763562]
12. Natalia F de la Fuente,Valentina A Puga,Luis I Cortínez,Hernán R Muñoz.  (2013-06-22)  The effective effect-site propofol concentration for induction in morbidly obese patients using total body weight with a new pharmacokinetic model..  Anesthesia and analgesia,  117  ((1)): (283-284).  [PMID:23788741]
13. Arslan Onuk Asuman,Arslan Baris,Karsli Bilge,Selen Bozkurt,Bülbüler Nurullah,Kahraman Meliha,Celik Umit.  (2013-07-10)  Changes in intraocular pressures during laparoscopy: a comparison of propofol total intravenous anesthesia to desflurane-thiopental anesthesia..  Middle East journal of anaesthesiology,  22  ((1)): (47-52).  [PMID:23833850]
14. Ming-Lian Yu,Yue Yang,Cong-Min Wang,Meng-Meng Zhang,Miao-Chun Bai,Yue-Ling Guo.  (2013-07-24)  Acitretin exhibits inhibitory effects towards UDP-glucuronosyltransferase (UGT)1A9-mediated 4-methylumbelliferone (4-MU) and propofol glucuronidation reaction..  Die Pharmazie,  68  ((6)): (449-452).  [PMID:23875253]
15. So-Hyun Jansen-Park,Sotirios Spiliopoulos,Hongyu Deng,Nick Greatrex,Ulrich Steinseifer,Dilek Guersoy,Reiner Koerfer,Gero Tenderich.  (2014-02-07)  A monitoring and physiological control system for determining aortic valve closing with a ventricular assist device..  European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,  46  ((3)): (356-360).  [PMID:24499877]
16. H Wang,Y Xie,Q Zhang,N Xu,H Zhong,H Dong,L Liu,T Jiang,Q Wang,L Xiong.  (2014-03-01)  Transcutaneous electric acupoint stimulation reduces intra-operative remifentanil consumption and alleviates postoperative side-effects in patients undergoing sinusotomy: a prospective, randomized, placebo-controlled trial..  British journal of anaesthesia,  112  ((6)): (1075-1082).  [PMID:24576720]
17. J B Glen,M White.  (2014-04-12)  A comparison of the predictive performance of three pharmacokinetic models for propofol using measured values obtained during target-controlled infusion..  Anaesthesia,  69  ((6)): (550-557).  [PMID:24720380]
18. Owen Dyer.  (2014-05-02)  The slow death of lethal injection..  BMJ (Clinical research ed.),  348  (g2670-g2670).  [PMID:24781110]
19. Weicheng Zhao,Shaoli Zhou,Weifeng Yao,Xiaoliang Gan,Guangjie Su,Dongdong Yuan,Ziqing Hei.  (2014-06-01)  Propofol prevents lung injury after intestinal ischemia-reperfusion by inhibiting the interaction between mast cell activation and oxidative stress..  Life sciences,  108  ((2)): (80-87).  [PMID:24878149]
20. Yoshinori Aoki,Kaori Yoshida,Daisuke Nishizawa,Shinya Kasai,Tatsuya Ichinohe,Kazutaka Ikeda,Ken-ichi Fukuda.  (2014-06-04)  Factors that affect intravenous patient-controlled analgesia for postoperative pain following orthognathic surgery for mandibular prognathism..  PloS one,  ((6)): (e98548-e98548).  [PMID:24893040]
21. Amadeu Gavaldà,Israel Ramos,Carla Carcasona,Elena Calama,Raquel Otal,José Luis Montero,Sonia Sentellas,Monica Aparici,Dolors Vilella,Joan Alberti,Jorge Beleta,Montserrat Miralpeix.  (2014-06-15)  The in\xa0vitro and in\xa0vivo profile of aclidinium bromide in comparison with glycopyrronium bromide..  Pulmonary pharmacology & therapeutics,  28  ((2)): (114-121).  [PMID:24928173]
22. H S Na,H J Shin,S B Kang,J W Hwang,S H Do.  (2014-08-19)  Effects of magnesium sulphate on coagulation after laparoscopic colorectal cancer surgery, measured by rotational thromboelastometry (ROTEM® )..  Anaesthesia,  69  ((12)): (1314-1321).  [PMID:25132158]
23. Jason A Campagna,Kevin Pojasek,David Grayzel,John Randle,Douglas E Raines.  (2014-08-30)  Advancing novel anesthetics: pharmacodynamic and pharmacokinetic studies of cyclopropyl-methoxycarbonyl metomidate in dogs..  Anesthesiology,  121  ((6)): (1203-1216).  [PMID:25170571]
24. G Landoni,F Guarracino,C Cariello,A Franco,R Baldassarri,G Borghi,R D Covello,C Gerli,M Crivellari,A Zangrillo.  (2014-09-05)  Volatile compared with total intravenous anaesthesia in patients undergoing high-risk cardiac surgery: a randomized multicentre study..  British journal of anaesthesia,  113  ((6)): (955-963).  [PMID:25186820]
25. Tao Yu,Xiao Peng,Ling Liu,Qing Li,Yingzi Huang,Fengmei Guo,Yi Yang,Haibo Qiu.  (2014-10-01)  Propofol increases preload dependency in septic shock patients..  The Journal of surgical research,  193  ((2)): (849-855).  [PMID:25266601]
26. M M Birck,A Vegge,S G Moesgaard,T Eriksen.  (2014-12-07)  Single port laparoscopic long-term tube gastrostomy in Göttingen minipigs..  Laboratory animals,  49  ((3)): (220-227).  [PMID:25480656]
27. Christoph Haller,Bianka Sobolewska,David Schibilsky,Meltem Avci-Adali,Christian Schlensak,Hans-Peter Wendel,Tobias Walker.  (2014-12-11)  One-staged aptamer-based isolation and application of endothelial progenitor cells in a porcine myocardial infarction model..  Nucleic acid therapeutics,  25  ((1)): (20-26).  [PMID:25494449]
28. Nadine Pinder,Johannes B Zimmermann,Stefan Hofer,Thorsten Brenner,Markus A Weigand,Ute Gubbe,Torsten Hoppe-Tichy,Stefanie Swoboda.  (2015-01-08)  Revival of physostigmine - a novel HPLC assay for simultaneous determination of physostigmine and its metabolite eseroline designed for a pharmacokinetic study of septic patients..  Clinical chemistry and laboratory medicine,  53  ((8)): (1259-1264).  [PMID:25565546]
29. Chang Seok Lee,Adan Dagnino-Acosta,Viktor Yarotskyy,Amy Hanna,Alla Lyfenko,Mark Knoblauch,Dimitra K Georgiou,Ross A Poché,Michael W Swank,Cheng Long,Iskander I Ismailov,Johanna Lanner,Ted Tran,KeKe Dong,George G Rodney,Mary E Dickinson,Christine Beeton,Pumin Zhang,Robert T Dirksen,Susan L Hamilton.  (2015-02-27)  Ca(2+) permeation and/or binding to CaV1.1 fine-tunes skeletal muscle Ca(2+) signaling to sustain muscle function..  Skeletal muscle,  (4-4).  [PMID:25717360]
30. Andrew Rowland,David Hallifax,Matthew R Nussio,Joseph G Shapter,Peter I Mackenzie,J Brian Houston,Kathleen M Knights,John O Miners.  (2015-03-25)  Characterization of the comparative drug binding to intra- (liver fatty acid binding protein) and extra- (human serum albumin) cellular proteins..  Xenobiotica; the fate of foreign compounds in biological systems,  45  ((10)): (847-857).  [PMID:25801059]
31. Niketh Kuruvilla,Ramesh Paramsothy,Raghubinder Gill,Warwick S Selby,Matthew L Remedios,Arthur J Kaffes.  (2015-04-07)  A prospective dual-center proof-of-principle study evaluating the incremental benefit of narrow-band imaging with a fixed zoom function in real-time prediction of polyp histology. Can we resect and discard?.  Gastrointestinal endoscopy,  82  ((2)): (362-369).  [PMID:25841577]
32. Brian P Weiser,Michael A Hall,Nathan L Weinbren,Kellie A Woll,William P Dailey,Maryellen F Eckenhoff,Roderic G Eckenhoff.  (2015-04-09)  Macroscopic and macromolecular specificity of alkylphenol anesthetics for neuronal substrates..  Scientific reports,  (9695-9695).  [PMID:25853337]
33. Nancy Witowski,Elizabeth Lusczek,Charles Determan,Daniel Lexcen,Kristine Mulier,Beverly Ostrowski,Greg Beilman.  (2015-04-16)  A four-compartment metabolomics analysis of the liver, muscle, serum, and urine response to polytrauma with hemorrhagic shock following carbohydrate prefeed..  PloS one,  10  ((4)): (e0124467-e0124467).  [PMID:25875111]
34. Achim Seeger,Patrick Krumm,Andreas Hornung,Jürgen F Schäfer,Ulrich Kramer,Ludger Sieverding.  (2015-04-24)  3-D cardiac MRI in free-breathing newborns and infants: when is respiratory gating necessary?.  Pediatric radiology,  45  ((10)): (1448-1454).  [PMID:25903840]
35. Matthias Jacquet-Lagrèze,Bernard Allaouchiche,Damien Restagno,Christian Paquet,Jean-Yves Ayoub,Jêrome Etienne,François Vandenesch,Olivier Dauwalder,Jeanne-Marie Bonnet,Stéphane Junot.  (2015-06-05)  Gut and sublingual microvascular effect of esmolol during septic shock in a porcine model..  Critical care (London, England),  19  (241-241).  [PMID:26041462]
36. Romain Hernu,Martin Cour,Sylvie de la Salle,Dominique Robert,Laurent Argaud.  (2015-06-17)  Cost awareness of physicians in intensive care units: a multicentric national study..  Intensive care medicine,  41  ((8)): (1402-1410).  [PMID:26077058]
37. Ufuk Kuyrukluyıldız,Orhan Binici,Didem Onk,Serap Ayhan Celik,Mumtaz Taner Torun,Edhem Unver,Adalet Ozcicek,Aysin Alagol.  (2015-07-02)  Comparison of dexmedetomidine and propofol used for drug-induced sleep endoscopy in patients with obstructive sleep apnea syndrome..  International journal of clinical and experimental medicine,  ((4)): (5691-5698).  [PMID:26131153]
38. Linnea Lentz,Yan Zhao,Matthew T Kelly,William Schindeldecker,Steven Goetz,Dwight E Nelson,Robert S Raike.  (2015-08-02)  Motor behaviors in the sheep evoked by electrical stimulation of the subthalamic nucleus..  Experimental neurology,  273  (69-82).  [PMID:26231574]
39. M Mukai,T Isobe,K Okada,M Murata,M Shigeyama,N Hanioka.  (2015-09-17)  Species and sex differences in propofol glucuronidation in liver microsomes of humans, monkeys, rats and mice..  Die Pharmazie,  70  ((7)): (466-470).  [PMID:26373207]
40. Chi Y Lo,Brian R Weil,Beth A Palka,Arezoo Momeni,John M Canty,Sriram Neelamegham.  (2015-10-05)  Cell surface glycoengineering improves selectin-mediated adhesion of mesenchymal stem cells (MSCs) and cardiosphere-derived cells (CDCs): Pilot validation in porcine ischemia-reperfusion model..  Biomaterials,  74  (19-30).  [PMID:26433489]
41. Andrew J Ingram,Katherine L Walker,Richard N Zare,Robert M Waymouth.  (2015-10-08)  Catalytic Role of Multinuclear Palladium-Oxygen Intermediates in Aerobic Oxidation Followed by Hydrogen Peroxide Disproportionation..  Journal of the American Chemical Society,  137  ((42)): (13632-13646).  [PMID:26444100]
42. Paloma Morillas-Sendín,Emilio Delgado-Baeza,María Jesús Delgado-Martos,Mónica Barranco,Juan Francisco del Cañizo,Manuel Ruíz,Begoña Quintana-Villamandos.  (2015-11-20)  Effects of Sevoflurane and Propofol on Organ Blood Flow in Left Ventricular Assist Devices in Pigs..  BioMed research international,  2015  (898373-898373).  [PMID:26583144]
43. Ungureanu Bogdan Silviu,Pirici Daniel,Mărgăritescu Claudiu,Larisa Săndulescu,Fronie Simona,Pătraşcu Ştefan,Şurlin Valeriu,Săftoiu Adrian.  (2015-12-09)  Endoscopic ultrasound-guided radiofrequency ablation of the pancreas: An experimental study with pathological correlation..  Endoscopic ultrasound,  ((4)): (330-335).  [PMID:26643702]
44. S Bache,L Stendell,N V Olsen,K S Olsen.  (2012-12-22)  Problems in obtaining sufficient anaesthesia with propofol and remifentanil: three cases, a test infusion, and a review..  British journal of anaesthesia,  110  ((5)): (741-746).  [PMID:23257992]
45. Janos Peter Baombe,Khuram Parvez.  (2013-01-01)  Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 1: is propofol safe in patients with egg anaphylaxis?.  Emergency medicine journal : EMJ,  30  ((1)): (79-80).  [PMID:23275463]
46. Mana Saraghi,Victor M Badner,Leonard R Golden,Elliot V Hersh.  (2013-07-31)  Propofol: an overview of its risks and benefits..  Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995),  34  ((4)): (252-258).  [PMID:23895562]
47. M M Sahinovic,U Beese,E H Heeremans,A Kalmar,K van Amsterdam,R J H M Steenbakkers,H Kuiper,R Spanjersberg,R J M Groen,M M R F Struys,A R Absalom.  (2013-11-05)  Bispectral index values and propofol concentrations at loss and return of consciousness in patients with frontal brain tumours and control patients..  British journal of anaesthesia,  112  ((1)): (110-117).  [PMID:24185608]
48. Chihiro Iwata,Chikara Abe,Mitsuhiro Nakamura,Hironobu Morita.  (2013-11-20)  Hypergravity exposure for 14 days increases the effects of propofol in rats..  Anesthesia and analgesia,  118  ((1)): (125-131).  [PMID:24247228]
49. Jaime Acquaviva,Suqin He,Chaohua Zhang,John-Paul Jimenez,Masazumi Nagai,Jim Sang,Manuel Sequeira,Donald L Smith,Luisa Shin Ogawa,Takayo Inoue,Noriaki Tatsuta,Margaret A Knowles,Richard C Bates,David A Proia.  (2014-05-03)  FGFR3 translocations in bladder cancer: differential sensitivity to HSP90 inhibition based on drug metabolism..  Molecular cancer research : MCR,  12  ((7)): (1042-1054).  [PMID:24784839]
50. Emre Erbabacan,Güniz M Köksal,Birsel Ekici,Güner Kaya,Fatiş Altındaş.  (2014-05-09)  Effects of different modes of ventilation and head position on the size of the vena jugularis interna..  Swiss medical weekly,  144  (w13946-w13946).  [PMID:24805819]
51. Young-Mo Kim,Yong-Bum Joo,Chan Kang,Jae-Hwang Song.  (2014-09-17)  Can ultrasound-guided nerve block be a useful method of anesthesia for arthroscopic knee surgery?.  Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA,  23  ((7)): (2090-2096).  [PMID:25223966]
52. K Kaskinoro,A Maksimow,S Georgiadis,J Långsjö,H Scheinin,P Karjalainen,S K Jääskeläinen.  (2014-10-01)  Electroencephalogram reactivity to verbal command after dexmedetomidine, propofol and sevoflurane-induced unresponsiveness..  Anaesthesia,  70  ((2)): (190-204).  [PMID:25266086]
53. Zaiqi Yang,Mengyuan Zhang,Gongming Wang,Pihong Wei,Shenqiang Gao.  (2014-10-18)  Identification of anesthetic-induced expression changes using DNA microarray..  Molecular medicine reports,  11  ((1)): (589-596).  [PMID:25323983]
54. Pier Alberto Testoni,Sabrina Testoni,Giorgia Mazzoleni,Cristian Vailati,Sandro Passaretti.  (2014-12-07)  Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6\xa0years: a prospective single-center study..  Surgical endoscopy,  29  ((9)): (2770-2780).  [PMID:25480624]
55. David W Green.  (2014-12-17)  Cardiac output decrease and propofol: what is the mechanism?.  British journal of anaesthesia,  114  ((1)): (163-164).  [PMID:25500400]
56. Jonathan A Goodwin,Kohsuke Kudo,Yutaka Shinohe,Satomi Higuchi,Ikuko Uwano,Fumio Yamashita,Makoto Sasaki.  (2014-12-17)  Susceptibility-Weighted Phase Imaging and Oxygen Extraction Fraction Measurement during Sedation and Sedation Recovery using 7T MRI..  Journal of neuroimaging : official journal of the American Society of Neuroimaging,  25  ((4)): (575-581).  [PMID:25511937]
57. Robert Damitz,Anuj Chauhan.  (2015-02-01)  Rapid dissolution of propofol emulsions under sink conditions..  International journal of pharmaceutics,  481  ((1-2)): (47-55).  [PMID:25636303]
58. Annette P N Kutter,Martina Mosing,Sonja Hartnack,Joanna Raszplewicz,Martina Renggli,Jacqueline Y Mauch,Christoph K Hofer.  (2015-03-06)  The influence of acute pulmonary hypertension on cardiac output measurements: calibrated pulse contour analysis, transpulmonary and pulmonary artery thermodilution against a modified Fick method in an animal model..  Anesthesia and analgesia,  121  ((1)): (99-107).  [PMID:25742632]
59. Yu Liu,Min Li,Do.  (2015-04-18)  Closed-loop control better than open-loop control of profofol TCI guided by BIS: a randomized, controlled, multicenter clinical trial to evaluate the CONCERT-CL closed-loop system..  PloS one,  10  ((4)): (e0123862-e0123862).  [PMID:25886041]
60. Masafumi Fujimoto,Shuhei Terasaki,Masaaki Nishi,Tatsuo Yamamoto.  (2015-06-19)  Response to rocuronium and its determinants in patients with myasthenia gravis: A case-control study..  European journal of anaesthesiology,  32  ((10)): (672-680).  [PMID:26086278]
61. Stephen Ridley Smith,Brian Draganic,Peter Pockney,Phillip Holz,Ryan Holmes,Brendan Mcmanus,Rosemary Carroll.  (2015-06-24)  Transversus abdominis plane blockade in laparoscopic colorectal surgery: a double-blind randomized clinical trial..  International journal of colorectal disease,  30  ((9)): (1237-1245).  [PMID:26099316]
62. J H Yang,S W Suh,Y-S Park,J-H Lee,B K Park,C H Ham,J W Choi.  (2015-07-01)  Change in body surface temperature as an ancillary measurement to motor evoked potentials..  Spinal cord,  53  ((11)): (827-834).  [PMID:26123207]
63. Hyo-Seok Na,Young-Tae Jeon,Hyun-Jung Shin,Ah-Young Oh,Hee-Pyoung Park,Jung-Won Hwang.  (2015-08-08)  Effect of Paralysis at the Time of ProSeal Laryngeal Mask Airway Insertion on Pharyngolaryngeal Morbidities. A Randomized Trial..  PloS one,  10  ((8)): (e0134130-e0134130).  [PMID:26252522]
64. Satu M Pokkinen,Kari Nieminen,Arvi Yli-Hankala,Maija-Liisa Kalliomäki.  (2015-08-11)  Persistent posthysterectomy pain: A prospective, observational study..  European journal of anaesthesiology,  32  ((10)): (718-724).  [PMID:26258656]
65. Michael Schwarzl,Nazha Hamdani,Sebastian Seiler,Alessio Alogna,Martin Manninger,Svetlana Reilly,Birgit Zirngast,Alexander Kirsch,Paul Steendijk,Jochen Verderber,David Zweiker,Philipp Eller,Gerald Höfler,Silvia Schauer,Kathrin Eller,Heinrich Maechler,Burkert M Pieske,Wolfgang A Linke,Barbara Casadei,Heiner Post.  (2015-09-06)  A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction..  American journal of physiology. Heart and circulatory physiology,  309  ((9)): (H1407-H1418).  [PMID:26342070]
66. Gabriela K Fragiadakis,Brice Gaudillière,Edward A Ganio,Nima Aghaeepour,Martha Tingle,Garry P Nolan,Martin S Angst.  (2015-12-15)  Patient-specific Immune States before Surgery Are Strong Correlates of Surgical Recovery..  Anesthesiology,  123  ((6)): (1241-1255).  [PMID:26655308]
67. Shuai Liu, Keming Zheng, Yilin Jiang, Susu Gai, Bohan Li, Dehai Li, Shuang Yang, Zhihua Lv.  (2023)  Biotransformation of Penindolone, an Influenza A Virus Inhibitor.  MOLECULES,  28  (3): (1479).  [PMID:36771146]
68. Ma Zijian, Ma Yang, Cao Xuefeng, Zhang Yunpeng, Song Tieying.  (2023)  Avenanthramide-C Activates Nrf2/ARE Pathway and Inhibiting Ferroptosis Pathway to Improve Cognitive Dysfunction in Aging Rats.  NEUROCHEMICAL RESEARCH,  48  (2): (393-403).  [PMID:36222956]
69. Jiang Tianze, Xie Laozhi, Zhou Songlei, Liu Yipu, Huang Yukun, Mei Ni, Ma Fenfen, Gong Jingru, Gao Xiaoling, Chen Jun.  (2022)  Metformin and histone deacetylase inhibitor based anti-inflammatory nanoplatform for epithelial-mesenchymal transition suppression and metastatic tumor treatment.  JOURNAL OF NANOBIOTECHNOLOGY,  20  (1): (1-21).  [PMID:36045429]
70. Yujie Tang, Shiyin Zhao, Zemin Peng, Zhen Li, Liang Chen, Pei Gan.  (2021)  Cu2O nanoparticles anchored on carbon for the efficient removal of propofol from operating room wastewater via peroxymonosulfate activation: efficiency, mechanism, and pathway.  RSC Advances,  11  (34): (20983-20991).  [PMID:35479351]
71. Bai Z. M., Li X. F., Yang Y., Yang Y. F., Lv D. R., Tang L. L..  (2021)  Propofol inhibited gastric cancer proliferation via the hsa-miR-328-3p/STAT3 pathway.  Clinical & Translational Oncology,  23  (9): (1866-1873).  [PMID:33772723]
72. Zifei Qin, Peile Wang, Shuyi Duan, Xiaoying Wan, Han Xing, Jing Yang, Xiaojian Zhang, Zhihong Yao, Xinsheng Yao.  (2021)  Potential Determinants for Metabolic Fates and Inhibitory Effects of Isobavachalcone Involving in Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Efflux Transporters.  JOURNAL OF PHARMACEUTICAL SCIENCES,  110  (2285).  [PMID:33610566]
73. Xinqiang Li, Han Xing, Zifei Qin, Jing Yang, Peile Wang, Xiaojian Zhang, Zhihong Yao, Xinsheng Yao.  (2020)  Potential metabolism determinants and drug–drug interactions of a natural flavanone bavachinin.  RSC Advances,  10  (58): (35141-35152).  [PMID:35515695]
74. Xing Han, Yang Jing, Ren Kaidi, Qin Zifei, Wang Peile, Zhang Xiaojian, Yao Zhihong, Gonzalez Frank J, Yao Xinsheng.  (2020)  Investigation on the metabolic characteristics of isobavachin in Psoralea corylifolia L. (Bu-gu-zhi) and its potential inhibition against human cytochrome P450s and UDP-glucuronosyltransferases.  JOURNAL OF PHARMACY AND PHARMACOLOGY,  72  (12): (1865-1878).  [PMID:32750744]
75. Li Yang, Xu Chunxia, Xu Jinjin, Qin Zifei, Li Shishi, Hu Liufang, Yao Zhihong, Gonzalez Frank J, Yao Xinsheng.  (2020)  Characterization of metabolic activity, isozyme contribution and species differences of bavachin, and identification of efflux transporters for bavachin-O-glucuronide in HeLa1A1 cells.  JOURNAL OF PHARMACY AND PHARMACOLOGY,  72  (12): (1771-1786).  [PMID:32648321]
76. Qin Zifei, Jia Mengmeng, Yang Jing, Xing Han, Yin Zhao, Yao Zhihong, Zhang Xiaojian, Yao Xinsheng.  (2020)  Multiple circulating alkaloids and saponins from intravenous Kang-Ai injection inhibit human cytochrome P450 and UDP-glucuronosyltransferase isozymes: potential drug–drug interactions.  Chinese Medicine,  15  (1): (1-18).  [PMID:32655683]
77. Yang Li, Jinjin Xu, Chunxia Xu, Zifei Qin, Shishi Li, Liufang Hu, Zhihong Yao, Frank J. Gonzalez, Xinsheng Yao.  (2020)  Metabolism and disposition of corylifol A from Psoralea corylifolia: metabolite mapping, isozyme contribution, species differences and identification of efflux transporters for corylifol A-O-glucuronide in HeLa1A1 cells.  XENOBIOTICA,  50  (8): (997-1008).  [PMID:32116078]
78. Li Wang, Xiaodan Hong, Zhihong Yao, Yi Dai, Guoping Zhao, Zifei Qin, Baojian Wu, Frank J. Gonzalez, Xinsheng Yao.  (2018)  Glucuronidation of icaritin by human liver microsomes, human intestine microsomes and expressed UDP-glucuronosyltransferase enzymes: identification of UGT1A3, 1A9 and 2B7 as the main contributing enzymes.  XENOBIOTICA,      [PMID:28443723]
79. Zhihong Yao, Shishi Li, Zifei Qin, Xiaodan Hong, Yi Dai, Baojian Wu, Wencai Ye, Frank J. Gonzalez, Xinsheng Yao.  (2017)  Characterization of human UDP-glucuronosyltransferases responsible for glucuronidation and inhibition of norbakuchinic acid, a primary metabolite of hepatotoxicity and nephrotoxicity component bakuchiol in Psoralea corylifolia L..  RSC Advances,  (83): (52661-52671).  [PMID:]
80. Chunli Qi,Jiangnan Fu,Huinan Zhao,Huijie Xing,Dong Dong,Baojian Wu.  (2018-02-14)  Identification of UGTs and BCRP as potential pharmacokinetic determinants of the natural flavonoid alpinetin..  Xenobiotica; the fate of foreign compounds in biological systems,  49  ((3)): (276-283).  [PMID:29436891]

Solution Calculators